Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney
AH Kurt, K Buyukafsar - European journal of pharmacology, 2013 - Elsevier
European journal of pharmacology, 2013•Elsevier
Vascular effects of the G protein-coupled oestrogen receptor1 (GPER-1) agonist, G1 (10− 7−
5× 10− 6M), the main oestrogenic hormone, 17β-estradiol (10− 9− 10− 4M), the NR3A1
agonist, PPT (10− 8− 10− 5M), the NR3A2 agonist DPN (10− 8− 10− 5M), and the classical
oestrogen receptor blocker but also a GPER agonist, ICI-182780 (10− 8− 3× 10− 6M), were
investigated on the perfusion pressure in the isolated rat kidney. To seek cellular
mechanisms involved in GPER-1-induced signalling we tested several compounds …
5× 10− 6M), the main oestrogenic hormone, 17β-estradiol (10− 9− 10− 4M), the NR3A1
agonist, PPT (10− 8− 10− 5M), the NR3A2 agonist DPN (10− 8− 10− 5M), and the classical
oestrogen receptor blocker but also a GPER agonist, ICI-182780 (10− 8− 3× 10− 6M), were
investigated on the perfusion pressure in the isolated rat kidney. To seek cellular
mechanisms involved in GPER-1-induced signalling we tested several compounds …
Vascular effects of the G protein-coupled oestrogen receptor1 (GPER-1) agonist, G1 (10−7−5×10−6M), the main oestrogenic hormone, 17β-estradiol (10−9−10−4M), the NR3A1 agonist, PPT (10−8−10−5M), the NR3A2 agonist DPN (10−8−10−5M), and the classical oestrogen receptor blocker but also a GPER agonist, ICI-182780 (10−8−3×10−6M), were investigated on the perfusion pressure in the isolated rat kidney. To seek cellular mechanisms involved in GPER-1-induced signalling we tested several compounds including the inhibitors of Rho-kinase (ROCK) (Y-27632), tyrosine kinase (genistein), p38MAPK (SB203580), p44/42MAPK (PD98059), protein kinase C (PKC) (GF109203X), Jun-kinase (JNK) (SP600125), phosphatidylinositol-3-kinase (PI3K) (LY294002), Ca2+ channels (nifedipine), GPER-1 (G15) and epidermal growth factor (EGF) receptor kinase (AG-1478). Moreover, the effect of saponin (50mg/ml) that was used for endothelium removal was explored on G1-elicited vascular action. G1, 17β-estradiol and ICI-182780 but not PPT and DPN induced vasoconstrictions in basal renal perfusion pressure. In contrast, G1 promoted vasodilatation when the perfusion pressure was elevated in advance by phenylephrine. G1-elicited vasoconstriction was not modified by endothelial removal; however, it was markedly inhibited by GPER-1 antagonist, G15. The vasoconstrictor response to G1 was also significantly attenuated by Y-27632, PD98059, SB203580, GF109203X, genistein, AG-1478, and nifedipine, but not LY294002 and SP600125. Western blotting indicated the expression of GPER-1 in renal artery, medulla and cortex of rat kidney. In conclusion, GPER-1 could substantially modulate vascular responses through a variety of signalling pathways including ROCK, PKC, p38 MAPK, p42/44 MAPK, tyrosine kinase, EGF receptor kinase and VOCC but not JNK or PI3K in isolated perfused rat kidney.
Elsevier